2706637-43-4
2706637-43-4
Chemical Structure
(Rac)-D3S-001
- No. CAS: 2706637-43-4
- Formula:C32H35F6N7O3
- Molecular Weight:679.66
InChIKey: JOLORSRKBHXPFT-RTZFKIBNSA-N
SMILES: FC(F)(F)C(C(C)=CC(N)=C1F)=C1C2CC3=NC(OC[C@@]45N(CCC5)C[C@@H](C4)F)=NC(N6C[C@@H](N(CC6)C(C(F)=C)=O)CC#N)=C3CO2
Biological Activity: (Rac)-D3S-001 is the racemate of D3S-001 (HY-160023)[1][2].
| Referencia número | Nombre del producto | Pureza | Descripciòn | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Rac)-D3S-001 | (Rac)-D3S-001 is the racemate of D3S-001 (HY-160023). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Zhang J, et al. D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities. Cancer Discov. 2024 May 8. [Content Brief]
- [2]. Zhang yang, et al.Pyrimidoheterocyclic compounds and application thereof. Patent. WO2021180181
Keywords
